News

Easton is pleased to announce that its first 3 main OTC products (Viorra, Skin Renou HA and Kenestrin Gel) are now ready to be ordered directly through its

Health Canada’s Natural and Non-Prescription Health Products Directorate (NNHPD) has issued natural product number (NPN), NPN 80060196 and NPN 80060197 with the claim that helps to maintain and

Currently, Liposomal Grb-2 is in a safety segment of a Phase II trial in combination with Ara-C for the treatment of AML. It is also being evaluated for

The company said that Balmex is an established brand among parents with products used for diaper rash, primarily in babies and an adult line for soothing skin irritations

Fabry disease results in abnormal tissue deposits of a particular fatty substance (called globotriaosylceramide, also referred to as GL-3 or Gb3) throughout the body. It is characterized by

The trial showed that vaccine efficacy was maintained across age groups, from 50 years to 70 years and above. HZ/su vaccine candidate is non-live and combines gE, a

LOWR HDV – 1 (LOnafarnib With and without Ritonavir-1) is a parallel dose comparison study which randomized subjects to receive different doses of lonafarnib with or without ritonavir

The results will also appear in forthcoming print issues of the journals. Merck acquired ZERBAXA as a part of its purchase of Cubist Pharmaceuticals. The publications report the

The safety profile observed in this trial is consistent with other trials of Arzerra and no new safety signals were observed. "Patients eventually stop responding to current CLL